Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

M. M. Patnaik, E. Padron, R. R. Laborde, T. L. Lasho, C. M. Finke, C. A. Hanson, J. M. Hodnefield, R. A. Knudson, R. P. Ketterling, A. Al-Kali, A. Pardanani, N. A. Ali, R. S. Komroji, A. Tefferi

Research output: Contribution to journalArticlepeer-review

135 Scopus citations

Fingerprint

Dive into the research topics of 'Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences